Pulmonary Targeted Inhalational Therapy for Neutrophillic Asthma Using a Novel Simvastatin-Rapamycin Dry Powder Inhalation Formulation
{{output}}
Neutrophillic asthma, characterized by persistent airway inflammation and poor corticosteroid responsiveness, presents a significant therapeutic challenge. Repurposing rapamycin, an mTOR inhibitor, and simvastatin, a statin with anti-inflammatory effects, thro... ...
